Eli Lilly vs. Novo Nordisk: How One Earnings Season Blew the GLP-1 Rivalry Wide Open
Eli Lilly and Novo Nordisk both beat earnings estimates, but investors reacted in opposite ways. Here’s why the gap between the two obesity-drug giants keeps…
obesity drug market